SOLARIS BIOTECHNOLOGY SRL

Their core work

Solaris Biotechnology is an Italian biotech SME that applies biological and biotechnological processes to environmental and resource challenges — specifically converting waste streams into usable fuels and developing chemical-free water treatment solutions. In the WASTE2FUELS project they contributed as an industrial partner to the development of next-generation biofuels from organic waste, bringing process or fermentation know-how into a large research consortium. Through their own PURA initiative they moved into the water sector, positioning a proprietary chemical-free purification and disinfection technology as a market-ready product. Their work sits at the intersection of industrial biotechnology, environmental remediation, and clean-process engineering.

What they specialise in

How they've shifted over time

Solaris began its H2020 journey as a participant in a large multi-partner RIA on waste-to-biofuels (2016-2018), suggesting an early positioning as a specialist contributor within collaborative research on circular bioeconomy. By 2020 they had pivoted to independently coordinating a small commercial feasibility study on water purification — a shift from research participation toward product development and market entry. The move from participant in a €270k RIA to coordinator of a €50k SME Phase 1 grant signals a strategic turn: less focus on upstream research, more focus on commercializing proprietary technology.

Solaris appears to be transitioning from research-stage bioprocess partner toward an independent product company, with water treatment as their likely commercial focus — making them most interesting for consortia or investors working on decentralized or chemical-free water solutions.

How they like to work

Solaris has experience on both sides of consortium leadership: as a specialist partner in a large RIA with many organizations, and as the lead in their own focused SME project. Their participation in WASTE2FUELS alongside 22 partners across 9 countries shows they can operate within complex international consortia. However, with only two projects on record, it is difficult to identify a consistent collaboration pattern — they appear opportunistic and adaptive rather than defined by a fixed role.

Solaris has worked with 22 unique consortium partners across 9 countries, almost entirely through their participation in the large WASTE2FUELS consortium. Their network is broad in geographic terms but thin in depth, as it reflects a single multi-partner project rather than repeated collaborations.

What sets them apart

Solaris combines industrial biotech expertise with a demonstrated move toward proprietary product development — rare for a small Italian SME in this space. Their PURA technology, if validated, positions them as a potential technology provider rather than just a research partner, which distinguishes them from university spinouts and pure-research SMEs. For a consortium needing an industrial biotech SME with both process know-how and a commercial product pipeline, they are a credible candidate — provided their PURA technology has progressed beyond the Phase 1 feasibility stage.

Highlights from their portfolio

• WASTE2FUELS
  Their largest funded project (€270k) placed them inside a significant multi-country RIA on next-generation biofuels from waste — evidence of recognized sector expertise at the time.
• PURA
  As coordinator of this SME Instrument Phase 1 grant, Solaris demonstrated enough confidence in a proprietary chemical-free water purification technology to lead their own EU-funded feasibility study.